Volume 102, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



infection negatively impacts children’s physical health and may influence general well-being. Schistosomiasis control programs aim at reducing morbidity through mass drug administration (MDA). This study aimed to compare morbidity markers between two cohorts of Tanzanian schoolchildren with initial high prevalence of infection. One cohort ( = 254 at baseline) received annual MDA for 4 years using community-wide treatment (CWT). The second cohort ( = 318 at baseline) received school-based treatment (SBT) every other year for 4 years. At year 5, the CWT cohort and the SBT cohort were reduced to 153 and 221 children, respectively. The characteristics of the 198 children lost to follow-up did not differ at baseline from those who were examined in year 5. infection hemoglobin (Hb) and anemia, physical fitness, and perceived quality of life were investigated at baseline, year 3, and year 5, whereas liver and spleen pathology (ultrasound) were investigated only at baseline and year 5. Cohorts were compared using two-way mixed-model analysis of variance (ANOVA). Both treatment regimens significantly decreased individual-level mean intensity of infection, anemia, and hepatomegaly, and increased Hb levels after 5 years. Hepatomegaly was the only parameter affected by the treatment regimen as the CWT approach reduced the percentage of individuals with hepatomegaly significantly more than the SBT approach. Both treatment regimens led to reduced physical fitness at year 5 compared with baseline. The modest impact of the two control strategies are probably due to initial low intensity of infection, ensuring low level of schistosomiasis-related morbidity.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Colley DG, Bustinduy AL, Secor WE, King CH, , 2014. Human schistosomiasis. Lancet 383: 22532264. [Google Scholar]
  2. Hotez PJ, Kamath A, , 2009. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3: e412. [Google Scholar]
  3. Hotez PJ, 2014. The global burden of disease study 2010. Interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 8: e2865. [Google Scholar]
  4. Mazigo HD, Nuwaha F, Kinung’hi SM, Morona D, de Moira AP, Wilson S, Heukelbach J, Dunne DW, , 2012. Epidemiology and control of human schistosomiasis in Tanzania. Parasit Vectors 5: 274. [Google Scholar]
  5. Olsen A, Kinung’hi S, Magnussen P, , 2015. Schistosoma mansoni infection along the coast of Lake Victoria in Mwanza region, Tanzania. Am J Trop Med Hyg 92: 12401244. [Google Scholar]
  6. WHO, 2006. Preventive Chemotherapy in Human Helminthiasis. Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers . Geneva, Switzerland: World Health Organization. [Google Scholar]
  7. Olsen A, Kinung’hi S, Magnussen P, , 2018. Comparison of the impact of different mass drug administration strategies on infection with Schistosoma mansoni in Mwanza region—a cluster randomized controlled trial. Am J Trop Med Hyg 99: 15731579. [Google Scholar]
  8. Kinung’hi S, Magnussen P, Kaatano G, Olsen A, , 2016. Infection with Schistosoma mansoni has an effect on quality of life, but not on physical fitness in schoolchildren in Mwanza region, north–western Tanzania: a cross-sectional study. PLoS Negl Trop Dis 10: e0005257. [Google Scholar]
  9. National Bureau of Statistics, 2012. Tanzania Population and Housing Census, 2012. Available at: http://www.nbs.go.tz/. Accessed May 13, 2019. [Google Scholar]
  10. Shen Y, 2017. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries. BMC Infect Dis 17: 652. [Google Scholar]
  11. Katz N, Chaves A, Pellegrino J, , 1972. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397400. [Google Scholar]
  12. Kinung’hi SM, Magnussen P, Kaatano GM, Kishamawe C, Vennervald BJ, , 2014. Malaria and helminth co-infections in school and preschool children: a cross–sectional study in Magu district, north–western Tanzania. PLoS One 9: e86510. [Google Scholar]
  13. Sullivan KM, Grummer-Strawn L, Parvanta I, , 2008. Haemoglobin adjustments to define anaemia. Trop Med Int Health 13: 12671271. [Google Scholar]
  14. WHO, 2007. Available at: https://www.who.int/growthref/en/. Accessed May 13, 2019.
  15. Bustinduy AL, Thomas CL, Fiutem JJ, Parraga IM, Mungai PL, Muchiri EM, Mutuku F, Kitron U, King CH, , 2011. Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric. PLoS Negl Trop Dis 5: e1213. [Google Scholar]
  16. Müller I, 2011. Effect of schistosomiasis and soil–transmitted helminth infections on physical fitness of school children in Côte d’Ivoire. PLoS Negl Trop Dis 5: e1239. [Google Scholar]
  17. Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM, , 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity . TDR/STR/SCH/00.1. Geneva, Switzerland: World Health Organization. [Google Scholar]
  18. Vennervald BJ, 2004. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Tropical Med Intern Health 9: 461470. [Google Scholar]
  19. Sircar AD, Mwinzi PNM, Onkanga IO, Wiegand RE, Montgomery SP, Secor WE, , 2018. Schistosoma mansoni mass drug administration regimens and their effect on morbidity among schoolchildren over a 5–year period–Kenya, 2010–2015. Am J Trop Med Hyg 99: 362369. [Google Scholar]
  20. Samuels AM, Matey E, Mwinzi PN, Wiegand RE, Muchiri G, Ireri E, Hyde M, Montgomery SP, Karanja DM, Secor WE, , 2013. Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya. Am J Trop Med Hyg 87: 874882. [Google Scholar]
  21. Mohamed I, Kinung’hi S, Mwinzi PNM, Onkanga IO, Andiego K, Muchiri G, Odiere MR, Vennervald BJ, Olsen A, , 2018. Diet and hygiene practices influence morbidity in schoolchildren living in schistosomiasis endemic areas along Lake Victoria in Kenya and Tanzania—a cross-sectional study. PLoS Negl Trop Dis 12: e6373. [Google Scholar]
  22. Booth M, 2004. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans R Soc Trop Med Hyg 98: 125136. [Google Scholar]
  23. Tukahebwa EM, Magnussen P, Madsen H, Kabatereine NB, Nuwaha F, Wilson S, Vennervald BJ, , 2013. A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria fishing community is required for association with highly prevalent organ related morbidity. PLoS Negl Trop Dis 7: e2268. [Google Scholar]

Data & Media loading...

Supplemental figures

  • Received : 06 Jun 2019
  • Accepted : 25 Sep 2019
  • Published online : 11 Nov 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error